Texas Yale Capital Corp. Abb Vie Inc. Transaction History

Texas Yale Capital Corp.

$2.28 Billion
Q3 2024

A detailed history of Texas Yale Capital Corp. transactions in Abb Vie Inc. stock. As of the latest transaction made, Texas Yale Capital Corp. holds 38,398 shares of ABBV stock, worth $7.06 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

38,398

Previous 38,398 -0.0%

Holding current value

$7.06 Million

Previous $6.59 Million 15.12%

% of portfolio

0.33%

Previous 0.32%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $54,176 - $63,266	-350 Reduced 0.9%	38,398 $6.59 Million
Q1 2024 May 08, 2024	BUY	$159.82 - $182.1 $7,991 - $9,105	50 Added 0.13%	38,748 $7.06 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $674,377 - $759,507	4,901 Added 14.5%	38,698 $6 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $40,077 - $46,395	-300 Reduced 0.88%	33,797 $5.04 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $72,880 - $90,695	550 Added 1.64%	34,097 $4.59 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $13,831 - $16,587	100 Added 0.3%	33,547 $5.42 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $23,486 - $26,937	-175 Reduced 0.52%	33,447 $4.49 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $37,845 - $48,114	275 Added 0.82%	33,622 $5.15 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $15,837 - $19,650	120 Added 0.36%	33,347 $5.41 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $58,549 - $74,081	545 Added 1.67%	33,227 $4.5 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $27,664 - $31,402	260 Added 0.8%	32,682 $3.53 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $34,719 - $38,679	330 Added 1.03%	32,422 $3.65 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $12,480 - $13,739	122 Added 0.38%	32,092 $3.47 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $20,122 - $27,167	250 Added 0.79%	31,970 $3.43 Million
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $1,202 - $1,411	-14 Reduced 0.04%	31,720 $2.78 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $137,715 - $184,283	1,877 Added 6.29%	31,734 $3.12 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $49,769 - $62,272	-690 Reduced 2.26%	29,857 $2.64 Million
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $2.01 Million - $2.57 Million	-30,547 Reduced 50.0%	30,547 $2.22 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $2.36 Million - $2.77 Million	30,547 Added 100.0%	61,094 $4.92 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $110,624 - $136,430	-1,421 Reduced 4.45%	30,547 $2.82 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $52,012 - $57,821	585 Added 1.86%	31,968 $3.02 Million
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $29,178 - $34,524	-325 Reduced 1.02%	31,383 $2.91 Million
Q4 2017 Feb 07, 2018	BUY	$89.56 - $98.21 $190,315 - $208,696	2,125 Added 7.18%	31,708 $3.07 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $2.07 Million - $2.64 Million	29,583	29,583 $2.63 Million

Others Institutions Holding ABBV

# of Institutions

3,891

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Yale Capital Corp., based on Form 13F filings with the SEC.

News

Stay updated on Texas Yale Capital Corp. with notifications on news.

Account

Texas Yale Capital Corp. Abb Vie Inc. Transaction History